Pharmena S.A. Stock Price

WSE:PHR Community·zł36.8m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
2 Fair Values set on narratives written by author

Create a narrative

PHR Share Price Performance

zł3.30

-0.92 (-21.80%)

zł3.30

-0.92 (-21.80%)

zł3.30

Tue, 6 Jan 26

Share Pricen/a

PHR Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks

1 Reward

View Full Analysis

Pharmena S.A. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: -0.20
: 84.54%
: -172.37%
: 0%

View Full Analysis

About PHR

Founded: 2002
Employees: 7
CEO: Konrad Palka
WebsiteView website: www.pharmena.eu

Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including face, hair, and body care products, as well as dietary supplement. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland.